Additionally, there were significantly higher levels of tumour apoptosis in BC-PDEs with a HER2 score of 3 + compared to those with HER2 scores of 2 + , 1 + or 0 (Fig. 6B), although there was a high degree of variance amongst these four samples. Here, ERBB2 is linked to breast cancer.